Improve the Quality of Life of Older Cancer Patients

Who we are — Korea University Anam Hospital (Family Medicine) & KIST

Two complementary Korean entities seeking to join a forming EU consortium under HORIZON-MISS-2026-02-CANCER-07 — Improve the Quality of Life of Older Cancer Patients. South Korea is a Horizon Europe Pillar II Associated Country, and both entities are eligible for direct EU funding and named work-package roles on equal terms with EU partners.

Why our contribution is distinctive

• Muscle-health focus for older cancer patients: sarcopenia, cachexia and frailty as key drivers of toxicity, loss of independence and poor QoL

• Clinical + technology integration: geriatric oncology care and prehabilitation combined with wearables, biosensors, AI risk prediction and multi-omics

• Translation-ready contribution: prospective cohort access, longitudinal follow-up, multimodal sensing and real-world data integration

Korea University Anam Hospital — Department of Family Medicine

Clinical & care-model strengths

• Geriatric & frailty assessment: validated CGA, SPPB, grip-strength and gait-speed protocols

• Sarcopenia & cachexia evaluation: CT/DEXA body-composition analysis, nutritional assessment and clinical biomarker work-up

• Prehabilitation & rehabilitation: structured exercise, nutritional and psychosocial programmes before and during cancer treatment

• Primary-care integration: bridging specialist oncology and community-level care to sustain QoL and independence

• Clinical cohort access: established older-patient population across diverse cancer types; capacity for prospective enrolment and longitudinal follow-up

KIST — Center for Advanced Biomolecular Recognition

Technology & data strengths

• AI-integrated sensing & risk prediction: ML models for frailty progression and QoL-decline prediction using multimodal sensor data

• EG-FET biomarker platforms: minimally invasive, real-time detection of myokines, cachexia markers and inflammatory signatures

• Wearables & continuous monitoring: sensor-fusion systems for longitudinal health-status tracking in free-living conditions

• Myokine & cachexia multi-omics: molecular characterization of muscle–organ crosstalk relevant to sarcopenia, cancer cachexia and treatment toxicity

What we can contribute as partners

• Clinical validation and intervention delivery for older cancer patients

• Muscle-health biomarker and sensing development

• Wearable-based longitudinal monitoring

• AI-supported risk modelling for frailty progression and QoL decline

• Multimodal data integration across clinical, sensor and molecular layers

• Named WP roles, including work-package co-leadership where relevant

The consortium we hope to join

We are looking for a forming consortium that brings complementary strengths — in particular:

• Geriatric oncology clinical sites across multiple EU Member States

• Patient / survivor / caregiver involvement

• SSH (social sciences, psychology, behavioural and caregiver research)

• HTA / health economics / implementation science

• Rehabilitation / prehabilitation

• EHDS / FAIR data / UNCAN.eu-aligned infrastructure

We would be happy to contribute as funded consortium partners and to take on clearly defined work-package roles within the consortium's structure.

Contact

Dr. Juyong Yoon | KIST Europe | juyong.yoon@kist-europe.de